SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001159036-22-000002
Filing Date
2022-01-10
Accepted
2022-01-10 08:12:12
Documents
46
Period of Report
2022-01-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K halo-20220110.htm   iXBRL 8-K 45252
2 EX-99.1 ex991halozyme_2022xoutlook.htm EX-99.1 42141
3 EX-99.2 ex992halozyme_corporatep.htm EX-99.2 30173
7 GRAPHIC ex992halozyme_corporatep001.jpg GRAPHIC 77424
8 GRAPHIC ex992halozyme_corporatep002.jpg GRAPHIC 236301
9 GRAPHIC ex992halozyme_corporatep003.jpg GRAPHIC 120345
10 GRAPHIC ex992halozyme_corporatep004.jpg GRAPHIC 72609
11 GRAPHIC ex992halozyme_corporatep005.jpg GRAPHIC 86116
12 GRAPHIC ex992halozyme_corporatep006.jpg GRAPHIC 91957
13 GRAPHIC ex992halozyme_corporatep007.jpg GRAPHIC 98528
14 GRAPHIC ex992halozyme_corporatep008.jpg GRAPHIC 83611
15 GRAPHIC ex992halozyme_corporatep009.jpg GRAPHIC 106156
16 GRAPHIC ex992halozyme_corporatep010.jpg GRAPHIC 99994
17 GRAPHIC ex992halozyme_corporatep011.jpg GRAPHIC 72599
18 GRAPHIC ex992halozyme_corporatep012.jpg GRAPHIC 99589
19 GRAPHIC ex992halozyme_corporatep013.jpg GRAPHIC 102394
20 GRAPHIC ex992halozyme_corporatep014.jpg GRAPHIC 88849
21 GRAPHIC ex992halozyme_corporatep015.jpg GRAPHIC 78128
22 GRAPHIC ex992halozyme_corporatep016.jpg GRAPHIC 106088
23 GRAPHIC ex992halozyme_corporatep017.jpg GRAPHIC 98635
24 GRAPHIC ex992halozyme_corporatep018.jpg GRAPHIC 77996
25 GRAPHIC ex992halozyme_corporatep019.jpg GRAPHIC 89403
26 GRAPHIC ex992halozyme_corporatep020.jpg GRAPHIC 89826
27 GRAPHIC ex992halozyme_corporatep021.jpg GRAPHIC 100622
28 GRAPHIC ex992halozyme_corporatep022.jpg GRAPHIC 96793
29 GRAPHIC ex992halozyme_corporatep023.jpg GRAPHIC 86754
30 GRAPHIC ex992halozyme_corporatep024.jpg GRAPHIC 89019
31 GRAPHIC ex992halozyme_corporatep025.jpg GRAPHIC 75282
32 GRAPHIC ex992halozyme_corporatep026.jpg GRAPHIC 88823
33 GRAPHIC ex992halozyme_corporatep027.jpg GRAPHIC 65958
34 GRAPHIC ex992halozyme_corporatep028.jpg GRAPHIC 120379
35 GRAPHIC ex992halozyme_corporatep029.jpg GRAPHIC 76640
36 GRAPHIC ex992halozyme_corporatep030.jpg GRAPHIC 77424
37 image_0a.jpg GRAPHIC 17587
38 image_1a.jpg GRAPHIC 18934
  Complete submission text file 0001159036-22-000002.txt   4258944

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20220110.xsd EX-101.SCH 1915
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20220110_lab.xml EX-101.LAB 24137
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20220110_pre.xml EX-101.PRE 12520
40 EXTRACTED XBRL INSTANCE DOCUMENT halo-20220110_htm.xml XML 10826
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 22519789
SIC: 2836 Biological Products, (No Diagnostic Substances)